This report contains market size and forecasts of Alpha1-Proteinase Inhibitor in global, including the following market information:
Global Alpha1-Proteinase Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alpha1-Proteinase Inhibitor Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Alpha1-Proteinase Inhibitor companies in 2021 (%)
The global Alpha1-Proteinase Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alpha1-Proteinase Inhibitor include Baxter, Kamada, Talecris Biotherapeutics, Aventis, CSL Behring and Grifols, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alpha1-Proteinase Inhibitor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alpha1-Proteinase Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Alpha1-Proteinase Inhibitor Market Segment Percentages, by Type, 2021 (%)
Powder
Liquid
Global Alpha1-Proteinase Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Alpha1-Proteinase Inhibitor Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Alpha1-Proteinase Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Alpha1-Proteinase Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alpha1-Proteinase Inhibitor revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alpha1-Proteinase Inhibitor revenues share in global market, 2021 (%)
Key companies Alpha1-Proteinase Inhibitor sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Alpha1-Proteinase Inhibitor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
Kamada
Talecris Biotherapeutics
Aventis
CSL Behring
Grifols